Lilly Research Laboratories

Lilly Research Laboratories

United States; Indiana United States; England United Kingdom; Indianapolis Indiana United States; Europe; Northern Europe; Americas; North America; Great Lakes
Is it you?
Investor info
Type
Corporate Venture Capital
Sweet spot
$10,000,000
Stage focus
  • Seed Round,
  • Early stage VC,
  • Later stage VC,
  • Other
Geography focus
United States; Europe; Global
Industry focus
Description
Eli Lilly is an Indianapolis-based pharmaceutical company and corporate venture investor that backs external biotech and life sciences innovation through Lilly Ventures, Lilly Gateway Labs, Lilly ExploR&D and Lilly Catalyze360. It invests and partners across early-stage and later-stage opportunities, with focus areas including oncology, genetic medicines, immunology, neuroscience, cardiometabolic health, digital health, AI-enabled discovery and molecule innovation. The company invests in the United States, Europe and globally, and is most relevant to founders building therapeutics, drug-discovery platforms or strategic biopharma technologies.
Previous investments
  • Company
    Amount
    Round
  • Example example company Inc
    1000000
    Investor meetings
  • Company & Company
    11000000
    Series C funding
  • Example
    524000
    Seed round A
Show more
Connected people
Email visible after logging in
  • Example Example
    Example Exampleexample[email protected]
  • Example Exampleexample
    Example Exampleexample
  • Notexample Examplenot
    Notexample Examplenotexample example[email protected]
  • Example Examplenotexample
    Example Examplenotexampleexample example[email protected]
  • Example Example
    Example Exampleexample[email protected]
  • Example Example
    Example Exampleexample[email protected]
Show more
X Feed
See other investors focused on
Biotechnology
Other investors you may be interested in
Made with in San Francisco, Berlin, Valencia, Oslo, Cherkasy and Warsaw© 2015-     Foundersuite, Inc.